Search Results

Observational Study for Pediatric Rheumatic Diseases: The CARRA Registry-STUDY00001129

The purpose of this study is to create and maintain a registry about children, adolescents, and young adults with pediatric onset of rheumatic...

Observational Study for Pediatric Rheumatic Diseases: The CARRA Registry-STUDY00001129B

The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry is an international registry of children and young adults with...

Managed Access Program (MAP) Cohort Treatment Plan CCTL019B2003I to provide access for patients with out of specification leukapheresis product and/or out of specification manufactured tisagenlecleucel (CTL019; Kymriah).-STUDY00002752

The purpose of this Managed Access Program (MAP), which is an intermediate size patient population Expanded Access, is to allow treatment with...

Integrating Multi-parametric Echocardiography with Computer Assisted Analyses in Detection for Early Allograft Rejection in Pediatric Heart Transplant Recipients: A Prospective Multicenter Pilot Trial (ECHO-EZ)-STUDY00003794

The aim of this project is to perform a prospective multicenter study comparing a standardized non-invasive, echocardiography-based allograft...

Adam Nicholas Cherry, ARNP, DNP, CPNP-AC

Adam Nicholas Cherry, ARNP, DNP, CPNP-AC, Advanced Registered Nurse Practitioner

Prone and Oscillation Pediatric Clinical Trial-STUDY00001794

To learn more about this study, please email the study team member listed below.

Ronelle E Caskey, ARNP

Ronelle E Caskey, ARNP specializing in Bladder and Bowel Health Program, Urology

AALL2131 An International Pilot Study of Chemotherapy and Tyrosine Kinase Inhibitors with Blinatumomab in Patients with Newly-Diagnosed Philadelphia Chromosome-Positive or ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leu-STUDY00005534

AALL2131 is a multi-center, international clinical trial designed to improve outcomes and reduce treatment-related toxicity in pediatric patients...

AALL1621, A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518, IND#133494) in Children and Young Adults with Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)-STUDY00000734

AALL1621 is a group-wide single-arm phase 2 study to evaluate the toxicity profile and preliminary efficacy of inotuzumab ozogamicin (InO) in...

Patrick B Solari, MD

Patrick B Solari, MD, Clinical Assistant Professor